[1] Vander BS,Komuta M,Libbrecht L,et al.Expression of multidrug resistance- associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumor phenotype and may reflect a progenitor cell origin [J]. Liver Int, 2008, 28(10)∶1370-1380 [2] 赵凌冰,王新星,李晓梅,等.P-gp和ABCG2在口腔鳞状细胞癌中的表达及临床病理意义[J].口腔医学研究,2012,28(1)∶32-35 [3] 郭宾, 戴仁科.代谢组学及其研究策略和分析方法进展[J].中国卫生检验杂志,2007,3(17)∶554-563 [4] Brecker L, Weber H, Griengl H,et al. In situ proton-NMR analyses of Escherichia coli HB101 fermentations in 1H2O and in D2O [J]. Microbiology, 1999, 145(Pt12)∶3389-3397 [5] Lenz EM, Wilson ID. Analytical strategies in metabonomics [J]. J Proteome Res, 2007, 6(2)∶443-458 [6] Lindon JC, Holmes E, Nicholson JK. So what's the deal with metabonomics [J]. Anal Chem, 2003, 75(17)∶384A-391A [7] Seger C, Sturm S. Analytical aspects of plant metabolite profiling platforms: current standings and future aims [J]. J Proteome Res, 2007, 6(2)∶480-497 [8] Sheedy JR, Ebeling PR, Gooley PR, et al. A sample preparation protocol for 1H nuclear magnetic resonance studies of water-soluble metabolites in blood and urine [J]. Anal Biochem, 2010, 398(2)∶263-265 [9] Holmes E, Nicholls AW, Lindon JC, et al. Development of a model for classification of toxin-induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition [J]. NMR Biomed, 1998, 11(4-5)∶235-244 [10] Griffin JL, Kauppinen RA. Tumour metabolomics in animal models of human cancer [J]. J Proteome Res, 2007, 6(2)∶498-505 [11] Tiziani S, Lopes V, Günther UL. Early stage diagnosis of oral cancer using 1H NMR-based metabolomics [J]. Neoplasia, 2009, 11(3)∶269-276 |